The priority for increasing the number of patent applications by Brazilian private companies, financial autonomy of the BPTO, and maintaining the fight against the patent backlog, among others, were the suggestions presented by ABPI in the meetings for the formulation of the National Intellectual Property Strategy – ENPI, carried out virtually in late March and early April, under the Ministry of Economy.
At the meetings, ABPI was represented by its president Luiz Edgard Montaury Pimenta, the 1st vice president Gabriel Leonardos, and lawyer Gustavo Morais, coordinator of this topic at ABPI. The association noted that the ENPI needs to take into account, in addition to pharmaceuticals, all technological areas. According to the BPTO, of the total of 831,936 patents and patent applications in force in Brazil, 65,077, or 7.8%, are related to drug patents, the rest being distributed in various technological areas. The suggestions made by ABPI were: